This week (22nd-30th April) is Primary Immunodeficiency (PI) Week. PI disorders are caused by hereditary genetic mutations that disrupt normal immune system functions making patients more susceptible to infection. There are more than 300 chronic PI disorders with a large range of symptoms making the disease difficult to diagnose.
PI is treated by preventing infection, alleviating symptoms, and boosting the immune system. More permanent treatments include, gene and stem cell therapy, but both treatments come with serious risks.
To raise awareness of World Primary Immunodeficiency Week, and improve diagnosis and treatment, the BSI has pooled together some of its most recent resources on the topic and will be posting on social media throughout the day.
Highlights of our resources
- Our infographics on Primary and Secondary Immunodeficiency
- Read our blog post to find out more about immunodeficiency and why it is important to support continued research
- Read our latest policy briefing on immunodeficiencies about current treatments and future research required to develop these treatments
- Learn more about the role antibodies play in immunodeficiency from our BiteSize article
- Read the latest Clinical and Experimental Immunology reviews on immunodeficiency
- The role of genomics in common variable immunodeficiency disorders
- Considerations for dosing immunoglobulin in obese patients
- Progressive multi-focal leucoencephalopathy – driven from rarity to clinical mainstream by iatrogenic immunodeficiency
- Chronic norovirus infection and common variable immunodeficiency
Follow our social media channels to find out more:
- BSI Twitter channel - @britsocimm
- BSI Facebook page
- BSI Instagram page - britsocimm
- Clinical & Experimental Immunology journal Twitter channel - @CEIjournal
- Immunology journal Twitter channel - @immjournal